Boston Sci’s Express SD Stent Gets New FDA Indication

Boston Scientific just won approval from the FDA for the company’s Express® SD Renal Stent System “as an adjunct to PTRA (percutaneous transluminal renal angioplasty) in certain lesions of the renal arteries.”
From the product page:

Design

Additional connections in the proximal end of the stent are designed to provide excellent support, especially in ostial lesions

Tandem Architecture™ Stent Design combines Micro™ and Macro™ Elements developed to balance strength, lumen coverage and deliverability

Deliverability

Based on Maverick® Monorail® Balloon Catheter technology, the design features a Laser-bonded tip engineered for improved tracking

0.014/0.018" compatible system, specifically developed for excellent access and superb performance

Low profile; 6F guide catheter-compatible up to 6.0mm

Press release: FDA Approves Boston Scientific’s Express® SD Renal Stent System …
Product page: Express® SD Renal Monorail® Premounted Stent System …